Tscan Therapeutics, Inc.
Clinical trials sponsored by Tscan Therapeutics, Inc., explained in plain language.
-
Custom immune cells take on multiple cancers in early trial
Disease control OngoingThis early-stage study tests a new treatment called T-Plex for people with advanced solid tumors (like head and neck, cervical, or melanoma) that haven't responded to standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab to recognize and…
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New screening aims to match cancer patients with personalized T-Cell treatments
Knowledge-focused OngoingThis study screens up to 1,150 adults with advanced solid tumors (like head and neck, cervical, or lung cancer) to see if they have the right genetic markers and tumor features for future T-cell therapies. Researchers will test blood and tumor samples for HLA type and other marke…
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:58 UTC